miR-532-5p inhibits the proliferation and invasion of BC cells by targeting high-mobility group protein B3 (HMGB3) and the Wnt/β-catenin signaling, but its expression in BC is down-regulated[27]. This evidence concerns the gene HMGB3 and breast cancer.